Updated Jul 16, 2026
Sandrock Alfred is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $184K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-03 | VYGR | Voyager Therapeutics, Inc. | S — Open-market sale | 11.5K | $3.87 | $45K |
| 2026-02-26 | VYGR | Voyager Therapeutics, Inc. | S — Open-market sale | 14.2K | $3.79 | $54K |
| 2026-02-20 | VYGR | Voyager Therapeutics, Inc. | S — Open-market sale | 11.7K | $3.41 | $40K |
| 2026-02-11 | VYGR | Voyager Therapeutics, Inc. | S — Open-market sale | 12.2K | $3.78 | $46K |
| 2026-02-10 | VYGR | Voyager Therapeutics, Inc. | A — Grant or award | 86.2K | $0.00 |
Sandrock Alfred is a corporate insider — currently tracked as President and CEO, Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($184K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sandrock Alfred profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.